Puma Leads Massive Biotech Surge As Esperion Hits 15-Month High | Investor's Business Daily
Stocktwits no Twitter: "Puma Biotechnology is tanking after-hours, down over -30% on the likelihood it won't get approval from European agency for its cancer drug. https://t.co/To0cg7EEgW $PBYI https://t.co/QMKqfhSV7l" / Twitter
Puma Biotechnology
StockTwits June 2017 Power Rankings: 10 Stocks You Have To Watch | by Stocktwits, Inc. | The Stocktwits Blog
Puma Biotechnology
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib - September 21, 2022 - Zacks.com
Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above Two Hundred Day Moving Average of $3.18 - ETF Daily News
Puma Biotechnology
NLP-of-StockTwits-data-for-predicting-stocks/FinALBERT_Pre_training.ipynb at master · mjag7682/NLP-of-StockTwits-data-for-predicting-stocks · GitHub